GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Il Yang Pharmaceutical Co Ltd (XKRX:007570) » Definitions » EV-to-FCF

Il Yang Pharmaceutical Co (XKRX:007570) EV-to-FCF : -8.02 (As of Apr. 11, 2025)


View and export this data going back to 1974. Start your Free Trial

What is Il Yang Pharmaceutical Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Il Yang Pharmaceutical Co's Enterprise Value is ₩280,801 Mil. Il Yang Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-35,008 Mil. Therefore, Il Yang Pharmaceutical Co's EV-to-FCF for today is -8.02.

The historical rank and industry rank for Il Yang Pharmaceutical Co's EV-to-FCF or its related term are showing as below:

XKRX:007570' s EV-to-FCF Range Over the Past 10 Years
Min: -747.51   Med: 32.1   Max: 1872.45
Current: -7.77

During the past 13 years, the highest EV-to-FCF of Il Yang Pharmaceutical Co was 1872.45. The lowest was -747.51. And the median was 32.10.

XKRX:007570's EV-to-FCF is ranked worse than
100% of 548 companies
in the Drug Manufacturers industry
Industry Median: 23.42 vs XKRX:007570: -7.77

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-11), Il Yang Pharmaceutical Co's stock price is ₩10060.00. Il Yang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₩557.000. Therefore, Il Yang Pharmaceutical Co's PE Ratio (TTM) for today is 18.06.


Il Yang Pharmaceutical Co EV-to-FCF Historical Data

The historical data trend for Il Yang Pharmaceutical Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Il Yang Pharmaceutical Co EV-to-FCF Chart

Il Yang Pharmaceutical Co Annual Data
Trend Mar15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.50 15.50 216.03 44.29 -8.72

Il Yang Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.29 24.72 26.99 -12.35 -8.72

Competitive Comparison of Il Yang Pharmaceutical Co's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Il Yang Pharmaceutical Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Il Yang Pharmaceutical Co's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Il Yang Pharmaceutical Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Il Yang Pharmaceutical Co's EV-to-FCF falls into.


;
;

Il Yang Pharmaceutical Co EV-to-FCF Calculation

Il Yang Pharmaceutical Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=280800.788/-35008.018
=-8.02

Il Yang Pharmaceutical Co's current Enterprise Value is ₩280,801 Mil.
Il Yang Pharmaceutical Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-35,008 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Il Yang Pharmaceutical Co  (XKRX:007570) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Il Yang Pharmaceutical Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=10060.00/557.000
=18.06

Il Yang Pharmaceutical Co's share price for today is ₩10060.00.
Il Yang Pharmaceutical Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩557.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Il Yang Pharmaceutical Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Il Yang Pharmaceutical Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Il Yang Pharmaceutical Co Business Description

Traded in Other Exchanges
Address
110, hagal-ro, Giheung-gu, Yongin-si, Seoul, Gyeonggi, KOR
Il Yang Pharmaceutical Co Ltd operates in the Korean healthcare sector. The company is mainly a pharmaceutical product manufacturer. Its business is comprised of four product divisions, which are Medicines, Food, Cosmetics, and Antacid raw materials. Its medicines include anticancer and antibiotics and drugs for the liver, digestive system, and anti-inflammatory drugs. Its Foods division is engaged in the manufacture and sale of food supplements and health drinks.

Il Yang Pharmaceutical Co Headlines

No Headlines